🇯🇵 MCI-186 in Japan

MCI-186 (MCI-186) regulatory status in Japan.

Marketing authorisation

MCI-186 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is MCI-186 approved in Japan?

Yes. PMDA has authorised it.

Who is the marketing authorisation holder for MCI-186 in Japan?

Tanabe Pharma Corporation is the originator. The local marketing authorisation holder may differ — check the official source linked above.